Adamas Pharmaceuticals
ADMS
#7889
Rank
ยฃ0.28 B
Marketcap
ยฃ6.28
Share price
0.00%
Change (1 day)
16,355.28%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): ยฃ64.53 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is ยฃ67.41 Million. In 2020 the company made a revenue of ยฃ56.91 Million an increase over the revenue in the year 2019 that were of ยฃ41.76 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ64.53 M13.38%
2020ยฃ56.91 M36.28%
2019ยฃ41.76 M60.48%
2018ยฃ26.02 M
2016ยฃ0.43 M-70.15%
2015ยฃ1.46 M-96.57%
2014ยฃ42.68 M-21.45%
2013ยฃ54.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
ยฃ50.46 B 74,755.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ51.50 B 76,301.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ34.12 B 50,518.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
ยฃ62.44 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
ยฃ0.66 B 880.97%๐Ÿ‡บ๐Ÿ‡ธ USA